EPCAM and benign prostatic hyperplasia: Although none of the novel transcripts were different between BPH and CaP, the multivariable analysis revealed an alternative combination of EPCAM, PSGR, PCA3 and % free PSA with AUC 0.753 (Table 3, Figure 1E).